On October 10, 2024, the Drug Enforcement Administration (the DEA) submitted a new rule to the White House Office of Management and Budget titled, “Third Temporary Extension of COVID-19 Telemedicine ...
Telemedicine startups that offer treatment for opioid abuse have benefited from a pandemic-era regulatory waiver that helped them greatly extend their reach. Now that exemption is set to end. Under a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback